Acadia wins Nuplazid patent case, extending protection to 2038, as JP Morgan boosts price target ahead of key appeal on the ‘740 COM patent.
Latest Ratings for ACAD
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 2022 | Cantor Fitzgerald | Maintains | Overweight | |
| Mar 2022 | Goldman Sachs | Maintains | Neutral | |
| Mar 2022 | Mizuho | Maintains | Neutral |
